MS News That Caught My Eye Last Week: Tysabri, Evobrutinib, Diet Study, Rituximab

MS News That Caught My Eye Last Week: Tysabri, Evobrutinib, Diet Study, Rituximab

287432

MS News That Caught My Eye Last Week: Tysabri, Evobrutinib, Diet Study, Rituximab

Drop in PML With Tysabri Use in Sweden Likely Due to Risk Management Plan I’m JCV-positive, so I’m at risk for PML if I’m being treated with Tysabri. And I was treated with Tysabri for seven years without a problem. That, I believe, is because my neurologist carefully followed me with MRIs and blood tests, and because I dropped back from monthly treatments to a treatment every other month after two years. My Tysabri protocol…

You must be logged in to read/download the full post.